These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12450704)

  • 1. The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol.
    Spooner ET; Desai RV; Mori C; Leverone JF; Lemere CA
    Vaccine; 2002 Dec; 21(3-4):290-7. PubMed ID: 12450704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42.
    Town T; Tan J; Sansone N; Obregon D; Klein T; Mullan M
    Neurosci Lett; 2001 Jul; 307(2):101-4. PubMed ID: 11427310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
    Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
    J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting".
    Leverone JF; Spooner ET; Lehman HK; Clements JD; Lemere CA
    Vaccine; 2003 May; 21(17-18):2197-206. PubMed ID: 12706711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.
    Liu B; Frost JL; Sun J; Fu H; Grimes S; Blackburn P; Lemere CA
    J Neurosci; 2013 Apr; 33(16):7027-37. PubMed ID: 23595760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
    Seabrook TJ; Thomas K; Jiang L; Bloom J; Spooner E; Maier M; Bitan G; Lemere CA
    Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants.
    Lemere CA; Spooner ET; Leverone JF; Mori C; Clements JD
    Neurobiol Aging; 2002; 23(6):991-1000. PubMed ID: 12470794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Abeta immunogens: is shorter better?
    Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
    Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
    Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
    Lemere CA
    Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
    Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
    J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
    Lambracht-Washington D; Qu BX; Fu M; Eagar TN; Stüve O; Rosenberg RN
    JAMA; 2009 Oct; 302(16):1796-802. PubMed ID: 19861672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
    Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
    J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
    Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
    Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.